Release Date: 27/02/14 20:10 Summary: Half Yearly Report and Accounts Price Sensitive: No Download Document 613.13KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%